Alex has over 12 years of equity research experience and six years of biopharma operating experience, bringing a unique perspective to evaluating investments.

Emily's steady support helps our team get the details right.

Karen has a long history of developing early stage technologies and launching them into the marketplace.

Lee has more than 21 years of experience in developing and leading research and development laboratories.

Matt is a CPA with over 20 years of experience and oversees the firm’s financial and administrative activities.

Antonio serves as the firm's Regional Advisor in Asia.

Glenda's broad strong organization skills help keep Pappas Capital running smoothly.

Lisa brings a depth of experience in finance and operations from her years in the Alternative Investments industry.

Geoff is an internationally recognized expert in genomics and personalized medicine.

Mike’s extensive company management background enables him to bring an operational viewpoint to new deal opportunities and existing portfolio companies.

Dr. Humer brings a wealth of leadership experience from the pharmaceutical and life science industries.

With long-standing interests in both basic and applied cancer research, Russel has held leadership positions in national academic organizations in internal medicine.

Ernie has 45 years of experience in the research-based pharmaceutical industry.

Tom has more than 26 years of executive management experience in the life sciences and medical device industry.

Jim has been a faculty member at Duke University for over 30 years, and is a highly regarded leader in the fields of neurology and neuroscience.

Barry has been a member of the Duke University faculty for 28 years. His broad base of expertise enables him to provide a distinctive view on portfolio companies.

Art has over 35 years of operating experience as a pharmaceutical and biotechnology industry executive and venture capital investor in life science companies.

Kyle’s deep scientific experience and extensive background in equity research and public market investing bring an important skill set to Pappas Capital.

Dave has an extensive career, holding senior level positions at companies such as Glaxo Inc., Glaxo Wellcome Inc., Warner Lambert Corporation and Boehringer Ingelheim Ltd.

Bob has an extensive background in the medical device industry, including the successful sale of TYRX to Medtronic in 2013.

Ford is a lawyer with an extensive background in finance and accounting, and currently serves as a Senior Advisor to Pappas Capital.

Peter has more than thirty-five years of experience in the biotech and pharmaceutical industries, and leads the firm's efforts in translational medicine.

Cookie comes from a multidisciplinary scientific background and is actively involved in evaluating investment opportunities for Pappas Capital.